Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 7 studies | 36% ± 14% | |
retinal pigment epithelial cell | 4 studies | 29% ± 12% | |
mast cell | 4 studies | 21% ± 5% | |
epithelial cell | 3 studies | 24% ± 10% | |
ciliated cell | 3 studies | 26% ± 4% | |
basal cell | 3 studies | 28% ± 8% | |
fibroblast | 3 studies | 22% ± 2% | |
glutamatergic neuron | 3 studies | 22% ± 4% | |
goblet cell | 3 studies | 30% ± 11% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 4953.78 | 1801 / 1809 | 97% | 42.14 | 457 / 472 |
prostate | 100% | 2083.42 | 244 / 245 | 96% | 21.44 | 481 / 502 |
esophagus | 99% | 3965.91 | 1437 / 1445 | 95% | 46.55 | 173 / 183 |
thymus | 100% | 3095.18 | 651 / 653 | 94% | 24.97 | 570 / 605 |
lung | 100% | 3587.92 | 577 / 578 | 93% | 39.66 | 1078 / 1155 |
bladder | 100% | 1562.43 | 21 / 21 | 92% | 26.10 | 463 / 504 |
uterus | 99% | 1866.70 | 169 / 170 | 88% | 35.42 | 404 / 459 |
stomach | 99% | 2095.91 | 356 / 359 | 87% | 19.73 | 249 / 286 |
intestine | 97% | 2229.42 | 937 / 966 | 89% | 20.75 | 470 / 527 |
kidney | 100% | 2365.02 | 89 / 89 | 81% | 12.63 | 732 / 901 |
brain | 95% | 2414.01 | 2502 / 2642 | 83% | 10.98 | 588 / 705 |
adrenal gland | 100% | 4014.95 | 258 / 258 | 77% | 13.84 | 177 / 230 |
breast | 95% | 1776.40 | 438 / 459 | 79% | 11.85 | 882 / 1118 |
ovary | 100% | 5124.89 | 180 / 180 | 67% | 9.47 | 288 / 430 |
pancreas | 42% | 389.30 | 137 / 328 | 87% | 12.85 | 154 / 178 |
muscle | 100% | 3189.38 | 801 / 803 | 0% | 0 | 0 / 0 |
spleen | 99% | 2744.85 | 239 / 241 | 0% | 0 | 0 / 0 |
heart | 98% | 4317.82 | 848 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 102.51 | 44 / 45 |
adipose | 97% | 1968.98 | 1163 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 15.12 | 76 / 80 |
blood vessel | 62% | 707.59 | 826 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 61% | 4970.19 | 570 / 929 | 0% | 0 | 0 / 0 |
liver | 13% | 125.44 | 29 / 226 | 18% | 2.50 | 73 / 406 |
lymph node | 0% | 0 | 0 / 0 | 28% | 2.34 | 8 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007154 | Biological process | cell communication |
GO_0006915 | Biological process | apoptotic process |
GO_0030279 | Biological process | negative regulation of ossification |
GO_0060173 | Biological process | limb development |
GO_0007275 | Biological process | multicellular organism development |
GO_0048681 | Biological process | negative regulation of axon regeneration |
GO_0016055 | Biological process | Wnt signaling pathway |
GO_0060828 | Biological process | regulation of canonical Wnt signaling pathway |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0043025 | Cellular component | neuronal cell body |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | KREMEN1 |
Protein name | Kringle containing transmembrane protein 1 Kremen protein 1 (Dickkopf receptor) (Kringle domain-containing transmembrane protein 1) (Kringle-containing protein marking the eye and the nose) |
Synonyms | KREMEN KRM1 |
Description | FUNCTION: Receptor for Dickkopf proteins. Cooperates with DKK1/2 to inhibit Wnt/beta-catenin signaling by promoting the endocytosis of Wnt receptors LRP5 and LRP6. In the absence of DKK1, potentiates Wnt-beta-catenin signaling by maintaining LRP5 or LRP6 at the cell membrane. Can trigger apoptosis in a Wnt-independent manner and this apoptotic activity is inhibited upon binding of the ligand DKK1. Plays a role in limb development; attenuates Wnt signaling in the developing limb to allow normal limb patterning and can also negatively regulate bone formation. Modulates cell fate decisions in the developing cochlea with an inhibitory role in hair cell fate specification. . |
Accessions | Q96MU8 ENST00000407188.5 [Q96MU8-1] ENST00000453585.1 ENST00000400335.9 [Q96MU8-3] H7BZ87 ENST00000327813.9 [Q96MU8-2] |